The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(3-Phenylpropoxy)-9-n-butyl-1-methyl-beta-carboline ID: ALA2314672
PubChem CID: 71575156
Max Phase: Preclinical
Molecular Formula: C25H28N2O
Molecular Weight: 372.51
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCCCn1c2cc(OCCCc3ccccc3)ccc2c2ccnc(C)c21
Standard InChI: InChI=1S/C25H28N2O/c1-3-4-16-27-24-18-21(28-17-8-11-20-9-6-5-7-10-20)12-13-22(24)23-14-15-26-19(2)25(23)27/h5-7,9-10,12-15,18H,3-4,8,11,16-17H2,1-2H3
Standard InChI Key: FWCJAYKBKGZZHP-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
10.5723 -22.8319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9067 -22.0846 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.4225 -21.4213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6120 -21.5095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2818 -22.2567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5004 -22.5073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7955 -22.0987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0864 -22.5073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0864 -23.3245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7955 -23.7331 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5004 -23.3245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2818 -23.5784 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.7578 -22.9159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0525 -23.4910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6769 -24.2931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4932 -24.3074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3773 -23.7331 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6716 -23.3209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9621 -23.7265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8893 -25.0222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7064 -25.0365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2562 -23.3149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5467 -23.7205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8431 -23.3054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1341 -23.7103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1302 -24.5283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8412 -24.9398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5472 -24.5325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
6 11 2 0
11 12 1 0
12 13 1 0
5 13 2 0
1 13 1 0
1 14 1 0
15 16 1 0
12 15 1 0
18 19 1 0
17 18 1 0
9 17 1 0
16 20 1 0
20 21 1 0
19 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 372.51Molecular Weight (Monoisotopic): 372.2202AlogP: 6.31#Rotatable Bonds: 8Polar Surface Area: 27.05Molecular Species: NEUTRALHBA: 3HBD: ┄#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 6.04CX LogP: 5.85CX LogD: 5.83Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.34Np Likeness Score: -0.34
References 1. Cao R, Fan W, Guo L, Ma Q, Zhang G, Li J, Chen X, Ren Z, Qiu L.. (2013) Synthesis and structure-activity relationships of harmine derivatives as potential antitumor agents., 60 [PMID:23291116 ] [10.1016/j.ejmech.2012.11.045 ]